BR0011648A - Método de fabricação de imunoglobulina intravenosa e produto resultante - Google Patents
Método de fabricação de imunoglobulina intravenosa e produto resultanteInfo
- Publication number
- BR0011648A BR0011648A BR0011648-3A BR0011648A BR0011648A BR 0011648 A BR0011648 A BR 0011648A BR 0011648 A BR0011648 A BR 0011648A BR 0011648 A BR0011648 A BR 0011648A
- Authority
- BR
- Brazil
- Prior art keywords
- globulin
- gamma
- resulting product
- manufacturing
- intravenous immunoglobulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33328999A | 1999-06-15 | 1999-06-15 | |
PCT/US2000/011870 WO2000076534A1 (en) | 1999-06-15 | 2000-06-06 | Manufacturing method for intravenous immune globulin and resultant product |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0011648A true BR0011648A (pt) | 2002-03-19 |
Family
ID=23302162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0011648-3A BR0011648A (pt) | 1999-06-15 | 2000-06-06 | Método de fabricação de imunoglobulina intravenosa e produto resultante |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1185290A4 (de) |
JP (1) | JP2003501480A (de) |
KR (1) | KR20020010921A (de) |
CN (1) | CN1358100A (de) |
AU (1) | AU756071B2 (de) |
BR (1) | BR0011648A (de) |
CA (1) | CA2375560A1 (de) |
CZ (1) | CZ20014456A3 (de) |
HK (1) | HK1048252A1 (de) |
IL (1) | IL146433A0 (de) |
PL (1) | PL352910A1 (de) |
WO (1) | WO2000076534A1 (de) |
ZA (1) | ZA200110168B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2437518A (en) * | 2006-04-26 | 2007-10-31 | Noel Kavanagh | Antiserum preparation |
WO2007136327A1 (en) * | 2006-05-22 | 2007-11-29 | Ge Healthcare Bio-Sciences Ab | A method of producing igg |
US7932356B1 (en) * | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
CA2941230C (en) | 2014-03-11 | 2020-08-25 | Green Cross Holdings Corporation | Method for purifying immunoglobulin |
CN106414476B (zh) * | 2014-03-11 | 2019-12-31 | 株式会社绿十字控股 | 用于纯化免疫球蛋白的方法 |
KR101941974B1 (ko) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | 혈장 단백질 정제시 fxi의 제거방법 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
FR2582515B1 (fr) * | 1985-05-30 | 1988-11-04 | Merieux Inst | Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues |
JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
CA2007545A1 (en) * | 1989-01-13 | 1990-07-13 | Yahiro Uemura | Production method for protein-containing composition |
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
JP3145696B2 (ja) * | 1990-10-05 | 2001-03-12 | 日本ケミカルリサーチ株式会社 | 分泌型免疫グロブリンa製剤の製造法 |
US5110910A (en) * | 1991-03-25 | 1992-05-05 | Miles Inc. | Virucidal euglobulin precipitation |
DE4431833C1 (de) * | 1994-09-07 | 1995-05-18 | Blutspendedienst Der Drk Lande | Verfahren zur Herstellung eines AHF-Konzentrates |
UA64742C2 (uk) * | 1997-12-24 | 2004-03-15 | Альфа Терапевтик Корпорейшн | СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ) |
-
2000
- 2000-06-06 IL IL14643300A patent/IL146433A0/xx unknown
- 2000-06-06 CZ CZ20014456A patent/CZ20014456A3/cs unknown
- 2000-06-06 BR BR0011648-3A patent/BR0011648A/pt not_active Application Discontinuation
- 2000-06-06 JP JP2001502867A patent/JP2003501480A/ja active Pending
- 2000-06-06 EP EP00942627A patent/EP1185290A4/de not_active Withdrawn
- 2000-06-06 PL PL00352910A patent/PL352910A1/xx not_active Application Discontinuation
- 2000-06-06 WO PCT/US2000/011870 patent/WO2000076534A1/en not_active Application Discontinuation
- 2000-06-06 CN CN00808372A patent/CN1358100A/zh active Pending
- 2000-06-06 KR KR1020017015561A patent/KR20020010921A/ko not_active Application Discontinuation
- 2000-06-06 CA CA002375560A patent/CA2375560A1/en not_active Abandoned
- 2000-06-06 AU AU57224/00A patent/AU756071B2/en not_active Expired
-
2001
- 2001-12-11 ZA ZA200110168A patent/ZA200110168B/en unknown
-
2003
- 2003-01-09 HK HK03100222.7A patent/HK1048252A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003501480A (ja) | 2003-01-14 |
CN1358100A (zh) | 2002-07-10 |
KR20020010921A (ko) | 2002-02-06 |
EP1185290A4 (de) | 2005-08-31 |
AU756071B2 (en) | 2003-01-02 |
CZ20014456A3 (cs) | 2002-05-15 |
EP1185290A1 (de) | 2002-03-13 |
HK1048252A1 (zh) | 2003-03-28 |
ZA200110168B (en) | 2002-08-26 |
CA2375560A1 (en) | 2000-12-21 |
AU5722400A (en) | 2001-01-02 |
WO2000076534A1 (en) | 2000-12-21 |
IL146433A0 (en) | 2002-07-25 |
PL352910A1 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2148332T3 (es) | Procedimiento para la produccion de concentrado de inmunoglobulinas g. | |
DK0721449T3 (da) | Inhibitorer af beta-amyloidproteinproduktion | |
TR200100377T2 (tr) | Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar. | |
BR0015508A (pt) | Gelatinas recombinantes, suas composições e processo de produção e emprego das mesmas | |
EP0414275A3 (en) | Process for the preparation of cyclic aminoacid derivitives as well as the intermediate products | |
HU9201329D0 (en) | The use of sulphonamides for medical purpose and process for the production of new sulphonamides | |
RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
FI101303B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 7-(2-tio-2-okso)metyyliamino-5-okso-pyrrolo- ja -6-okso-pyrido- ja -pyratsino[2,1-a][2]bentsatsepiini- ja -oksatsino- ja -tiatsino[3,4-a][2]bentsatsepiini-4-karboksyylihappojohdannaisten valmistamiseksi | |
DE59310085D1 (de) | Indolocarbazol-imide und deren verwendung | |
HU912485D0 (en) | Process for producing diazines | |
BG106249A (en) | Composition of a-beta peptide and process for producing same | |
DE3230849A1 (de) | Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung | |
RU93051352A (ru) | Замещенные производные циклогексана, способ их получения и применение соединений для лечения заболеваний | |
DE60328747D1 (de) | Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen | |
BR0011648A (pt) | Método de fabricação de imunoglobulina intravenosa e produto resultante | |
BR9807598A (pt) | Processo de produção para globulina de soro imunológico intravenoso e produto resultante | |
ES2129068T3 (es) | Tratamiento de productos alimentarios. | |
BR0010815A (pt) | Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa | |
NO931476L (no) | Fremgangsmaate ved fremstilling av en virussikker, hoeyrenset faktor viii | |
DE69331479D1 (de) | Polyethylenglycol-Hirudin-Konjugate, deren Verfahren zur Herstellung und Verwendung für die Heilung von Thrombosen | |
ATE151776T1 (de) | Cytotoxische und antivirale verbindung | |
FR2610633B1 (fr) | Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament | |
DE60022960D1 (de) | Verfahren zur Reinigung von S-Adenosyl-L-Methionin und zur Herstellung von pharmazeutisch verträglichen Salzen davon | |
ES2053606T3 (es) | Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza. | |
DK632187A (da) | Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII), 11 E 13 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |